Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Evert B. Schimmelpennink currently holds 19,000 shares of LENZ Therapeutics, Inc. (LENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evert B. Schimmelpennink has been a net buyer of LENZ stock. They have purchased $301.8K and sold $0 worth of shares.
Evert B. Schimmelpennink's most recent insider trade was on Jun 26, 2026, when they sold 19,000 shares at $0.00 per share.
Evert B. Schimmelpennink serves as Executive at LENZ Therapeutics, Inc. (LENZ). They have executed 16 insider transactions totaling $301.8K over their tenure at the company.
Evert B. Schimmelpennink holds the position of Executive at LENZ Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Evert B. Schimmelpennink has shown a buying trading pattern, with $301.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Evert B. Schimmelpennink was on Mar 27, 2026, when they purchased $251.4K worth of LENZ shares. This transaction involved 28,089 shares at $8.95 per share.
Evert B. Schimmelpennink currently owns 19,000 shares of LENZ Therapeutics, Inc. (LENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Evert B. Schimmelpennink's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Evert B. Schimmelpennink has 16 Form 4 filings on record as an insider at LENZ Therapeutics, Inc..
Set alerts for Evert B. Schimmelpennink and 40,000+ other insiders.